Sebastian M.
- Country
- Germany
- Department
- Klinik I für Innere Medizin
Research Overview
- Phase 2 Open‑Label Multicohort Study of Rinatabart Sesutecan Monotherapy in Patients with Locally Advanced or Metastatic Non‑Small Cell Lung Cancer
- Phase 1/2 Dose-Escalation and Expansion Study of Oral ALK Molecular Glue Degrader TRI-611 in Advanced ALK‑Positive Non‑Small Cell Lung Cancer
- Phase 3 Randomized Open‑Label Trial of ABBV‑706 versus Standard of Care in Relapsed/Refractory Small Cell Lung Cancer
Data & Insights
Has run more than one trial at 71 of 179 partner sites.
Specializations
Lung Cancer Therapeutics
This investigator specializes in treating advanced non-small cell lung cancer (NSCLC), with particular emphasis on cases involving specific genetic mutations. Their research encompasses innovative approaches to targeted therapy and treatment optimization.
- EGFR-mutated NSCLC management
- ALK-positive tumor treatment
- Advanced solid tumors
The investigator focuses on developing personalized treatment strategies for patients with specific genetic alterations.
Molecular Targeting
The investigator's work centers on evaluating novel therapeutic approaches targeting specific molecular pathways, including EGFR tyrosine kinase inhibitors and bispecific antibodies.
- Resistance mutation studies
- Combination therapy approaches
- Biomarker-driven treatment
Their research explores innovative treatment combinations to enhance therapeutic outcomes in resistant disease.
Clinical Innovation
The investigator evaluates novel drug delivery methods and treatment modalities, including subcutaneous administration of targeted therapies and biomarker-guided treatment escalation strategies.
- Treatment optimization studies
- Drug delivery innovation
- Pharmacokinetic assessment
Their work includes investigating various administration routes to improve treatment efficacy and patient experience.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.